Trending...
- Currier Repeats as Transition Player of the Year, Del Bianco and Harris Take Home First Awards
- Man City's Haaland, Fulham's Ream Claim Inaugural Men in Blazers 'American Football Awards'
- Score Shot Back to Sponsor the 2023 IDPA World Championship
MELBOURNE, Australia - iSportsWire -- Avion Medical Skin Centres (AMSC) have entered into an agreement with OncoBeta® GmbH to treat non-melanoma skin cancer (NMSC) patients in Australia, with the new, non-invasive [1] [2] Rhenium-SCT®. The first AMSC location will open in Melbourne Victoria, to patients in Q3 2022. Treatments will be provided at a brand-new world-class facility at the Melbourne Theranostics Innovation Centre (MTIC) in North Melbourne, which provides unparalleled access to a combination of nuclear medicine technologies, therapeutics and innovative research.
AMSC is partnering with Munich-based medical device and radiochemical company, OncoBeta, who are pioneering epidermal radioisotope therapy and successfully launched Rhenium-SCT – which is set to change the way people think about NMSC treatment. Where traditional treatment methods typically involve surgery, which may have a risk of scarring or loss of function, treatment with Rhenium-SCT employs a non-invasive [1] [2] superficial application of a paste containing ß-emitting particles directly to the lesion, which eliminate cancer cells without the need for surgery. Treatment with Rhenium-SCT is painless [1] [2] and only requires a single session [1] [2] [3] [4] [5] in most cases.
Dr. Sam Vohra, founder of AMSC, says, "We are very proud to be opening this new treatment centre in the heart of Melbourne's oncology precinct and to offer this ground-breaking treatment to NMSC patients in Australia. The clinical evidence has already proven that Rhenium-SCT is an effective alternative to traditional invasive options and can significantly improve patient outcomes and quality of life."
More on iSports Wire
Professor Rod Hicks, a pioneer of therapeutic nuclear medicine and founder of MTIC notes, "The use of externally applied radioisotopes to successfully cure skin cancers goes back to the start of the last century and the discovery of radium by Marie Curie. We have known for over a hundred years that this approach works but the Oncobeta approach brings this treatment into the 21st century with high precision in the application of radiation only to the skin cancer, sparing normal skin and without the disfiguring surgery sometimes otherwise required."
Shannon D. Brown III, CEO and Managing Director at OncoBeta, recently visited Australia, and says "We are focused on providing Rhenium-SCT in countries with the highest need, to provide as many patients as possible with beneficial clinical outcomes and positive effect on patients' quality of life. We are extremely excited for this partnership with Avion Medical Skin Centres and continuing to support physicians involved in the diagnosis and treatment of NMSCs."
Australia has the highest incidence of NMSC in the world, and diagnosis rates are continuing to rise each year [6] [7]. NMSCs are most common in areas that are exposed to the sun, including the face, head and neck/shoulders [8]. Avion Medical Skin Centres offers NMSC sufferers a highly effective [2] treatment option that removes the fear and hesitation some patients may feel around aesthetic outcomes or loss of function.
For more information about Avion Medical Skin Centres please visit www.avionmedicalskin.com.au or for more information about OncoBeta and Rhenium-SCT please visit: www.oncobeta.com.
More on iSports Wire
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of Avion Medical's control, and which could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning Avion Medical's plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. Avion Medical undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
For media enquiries, please contact via email: press@showoffgroup.com
References
AMSC is partnering with Munich-based medical device and radiochemical company, OncoBeta, who are pioneering epidermal radioisotope therapy and successfully launched Rhenium-SCT – which is set to change the way people think about NMSC treatment. Where traditional treatment methods typically involve surgery, which may have a risk of scarring or loss of function, treatment with Rhenium-SCT employs a non-invasive [1] [2] superficial application of a paste containing ß-emitting particles directly to the lesion, which eliminate cancer cells without the need for surgery. Treatment with Rhenium-SCT is painless [1] [2] and only requires a single session [1] [2] [3] [4] [5] in most cases.
Dr. Sam Vohra, founder of AMSC, says, "We are very proud to be opening this new treatment centre in the heart of Melbourne's oncology precinct and to offer this ground-breaking treatment to NMSC patients in Australia. The clinical evidence has already proven that Rhenium-SCT is an effective alternative to traditional invasive options and can significantly improve patient outcomes and quality of life."
More on iSports Wire
- Pettit Kohn Welcomes Esteemed Attorney John E. Drazkowski to the Arizona Team
- Peak Physical Therapy & Sports Performance Expands Golf Performance Program at Braintree Clinic
- INshed Now Offers Nationwide Shipping of Fully-Assembled, Eco-Friendly Backyard Offices
- Entrinsik Appoints Madhavi W. Chandra as Chief Product Officer
- Golden Ticket Productions Launches New Website
Professor Rod Hicks, a pioneer of therapeutic nuclear medicine and founder of MTIC notes, "The use of externally applied radioisotopes to successfully cure skin cancers goes back to the start of the last century and the discovery of radium by Marie Curie. We have known for over a hundred years that this approach works but the Oncobeta approach brings this treatment into the 21st century with high precision in the application of radiation only to the skin cancer, sparing normal skin and without the disfiguring surgery sometimes otherwise required."
Shannon D. Brown III, CEO and Managing Director at OncoBeta, recently visited Australia, and says "We are focused on providing Rhenium-SCT in countries with the highest need, to provide as many patients as possible with beneficial clinical outcomes and positive effect on patients' quality of life. We are extremely excited for this partnership with Avion Medical Skin Centres and continuing to support physicians involved in the diagnosis and treatment of NMSCs."
Australia has the highest incidence of NMSC in the world, and diagnosis rates are continuing to rise each year [6] [7]. NMSCs are most common in areas that are exposed to the sun, including the face, head and neck/shoulders [8]. Avion Medical Skin Centres offers NMSC sufferers a highly effective [2] treatment option that removes the fear and hesitation some patients may feel around aesthetic outcomes or loss of function.
For more information about Avion Medical Skin Centres please visit www.avionmedicalskin.com.au or for more information about OncoBeta and Rhenium-SCT please visit: www.oncobeta.com.
More on iSports Wire
- Aquia Launches Amazon Web Services (AWS) Cloud Security Assessment Offering, Pairing Automation With Deep Cloud Security Expertise
- Orbex Launches New ZERO Spread Trading Account with $1 Commission per Side
- Alpha Gold Fund Receives Recognition Of Excellence Awards
- Ren Shin Kan: Aiming for Victory at the UK Iaido Championships
- AthleteFocus Helps Soccer Players to get better after every game
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of Avion Medical's control, and which could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning Avion Medical's plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. Avion Medical undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
For media enquiries, please contact via email: press@showoffgroup.com
References
- Sedda AF, et al. Clin Exper Dermatol. 2008;33:745–749.
- Cipriani C, et al. J Dermatol Treat. 2020; DOI: 10.1080/09546634.2020.1793890.
- Castellucci P, et al. Eur J Nucl Med Mol Imaging. 2021;48:1511–1521.
- Cipriani C, et al. International Journal of Nuclear Medicine. 2017; July: 114–112.
- Cipriani C, et al. Epidermal Radionuclide Therapy - Springer, 2014.
- Lomas A, Leonardi-Bee J, Bath-Hextall F. 2012 May;166(5):1069-80. doi: 10.1111/j.1365-2133.2012.10830.x.
- Diepgen TL & Mahler VM. Br J Dermatol. 2002;146 (Suppl 61):1–6.
- Cancer Council Australia. https://www.cancer.org.au/cancer-information/types-of-cancer/non-melanoma-skin-cancer (accessed June 2022).
Source: Avion Medical Skin Centres
0 Comments
Latest on iSports Wire
- Dancing Numbers Unveils Google Sheets QuickBooks Integration, Streamlining Data Import, Export, and Deletion
- Man City's Haaland, Fulham's Ream Claim Inaugural Men in Blazers 'American Football Awards'
- Currier Repeats as Transition Player of the Year, Del Bianco and Harris Take Home First Awards
- ReadyCommunities Partnership of CCROA Announces National Service Awardees Who Helped Save Passengers from the Derailed Train Near Rural Mendon
- Bitcoin Mining Capacity Reaches 350 Exahashes/second
- Up To 70% Off! Alibonnie Graduation Season Wig Surprise Discount
- Gemini IT Producer Software is Reshaping the Filmmaking Industry
- Mighty Mussels hosting 'Faith & Family Night' on June 3
- 130k+ Patients' Social Security Numbers Leaked in UHS of Delaware Data Breach
- Sip Social Co. Mobile Bar Trucks Showcased At BC Home + Garden Show Presents New Opportunities To Partner With Marketplace Events
- Men in Blazers Media Network Expands Reach With Launch of First-Ever 'American Football Awards'
- Ohio Pacing Stallion Catch The Fire Is Heading To Australia
- IntellaTriage Names Olivia Gaffney, RN as 2022 Nurse of the Year Honoree
- Autel Robotics Wins Prestigious Red Dot Design Award 2023 for EVO Max 4T Drone
- Launch of New Industrial Capabilities and Services Website for Argo Products in St. Louis, Missouri
- SafeBreak® Vascular Cleared for Pediatrics
- CartoVista unveils CartoVista Cloud 8.1, the latest in GIS web mapping platforms, at 2023 FCM Conference in Toronto
- CartoVista unveils CartoVista Cloud at the 2023 FCM Conference in Toronto
- Resurgence Wellness Unveils Revolutionary Anti-Aging Breakthroughs by Tech Pioneer Bryan Johnson
- Calgary's Malawsky, Rochester's Carey Win Les Bartley Award and NLL General Manager of the Year